Quality of life in the first 100 days after suspected acute myocardial infarction--a suitable trial endpoint?

Abstract

The number of quality adjusted days lost after acute myocardial infarction is a practicable measurement that is relevant to patients' lives. It might be suitable as an outcome measure for clinical trials of thrombolytic therapy.